About Index Trending news
Analyze
Top 50 Pricing
OrbiMed Advisors

OrbiMed Advisors

Work at OrbiMed Advisors? Add yourself to this profile

Elsewhere

Alexa global traffic share

26.7M USD VC (Undisclosed) in Jul, 2015
100.0M USD Series D in Jan, 2016
60.0M USD Series B in Jun, 2015
6.0M USD Series A in Mar, 2014
50.0M USD VC (Undisclosed) in Oct, 2015
21.0M USD Series B in Jan, 2014
10.3M USD Venture capital in Jun, 2010
75.0M USD Series C in Mar, 2016
33.0M USD Venture capital in Apr, 2014
55.5M USD Series F in Apr, 2015
120.0M USD Series F in Oct, 2014
14.0M USD Series B in Apr, 2012
35.0M USD Venture capital in Aug, 2012
15.0M USD Series C in Apr, 2010
42.5M USD Series B in Dec, 2014
14.5M USD Series B in Apr, 2013
68.0M USD Series C in Apr, 2016
8.2M USD Series D in Jan, 2010
25.0M USD Venture capital in Nov, 2011
Exit: Merit Medical Systems for $97.5M on Jul 6, 2016
40.0M USD Series E in May, 2014
47.5M USD Series D in Jan, 2012
15.0M USD Series G in Jun, 2013
45.0M USD Series C in May, 2006
65.0M USD Series C in Mar, 2012
28.8M USD Series C in May, 2011
39.0M USD Series E in Aug, 2010
50.0M USD Series B in Apr, 2014
35.0M USD Series C in Mar, 2014
30.0M USD Series F in Feb, 2013
9.1M USD Venture capital in Jun, 2007
Exit: Jazz Pharmaceuticals for $650M on Apr 26, 2012
10.0M USD Series B in Feb, 2014
30.0M USD Series C in Aug, 2012
38.0M USD Series C in Mar, 2014
67.0M USD Series A in Jan, 2016
100.0M USD Post-IPO equity in Jun, 2016
48.0M USD Series A in Jun, 2016

Want to see the complete list?
Go Pro!